This is a preview of subscription content, log in via an institution to check access.
References
Song JY, Pittaluga S, Dunleavy K, Grant N, White T, Jiang L, Davies-Hill T, Raffeld M, Wilson WH, Jaffe ES (2015) Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations. Am J Surg Pathol 39(2):141–156. https://doi.org/10.1097/PAS.0000000000000328
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390. https://doi.org/10.1182/blood-2016-01-643569
Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES (1996) Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 87(11):4531–4537
Fauci AS, Haynes BF, Costa J, Katz P, Wolff SM (1982) Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med 306(2):68–74. https://doi.org/10.1056/NEJM198201143060203
Gaha M, Souillard-Scemama R, Miquel C, Godon-Hardy S, Naggara O, Meder JF (2013) MR imaging of the brain and spinal cord in lymphomatoid granulomatosis: a case report and review of the literature. J Neuroradiol 40(5):364–367. https://doi.org/10.1016/j.neurad.2012.12.001
Fujimaki M, Kawajiri S, Ichikawa K, Tomizawa Y, Nakazato T, Noda K, Hattori N, Koike M, Okuma Y (2015) Lymphomatoid granulomatosis with central nervous system involvement successfully treated with cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER therapy) followed by brain irradiation: a case study. CNS Neurosci Ther 21(7):610–612. https://doi.org/10.1111/cns.12414
Nishihara H, Nakasato M, Sawa H, Murakami H, Yamamoto D, Moriyama K, Kato N, Hashimoto I, Kamada H, Tanaka S (2009) A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings. J Neuro-Oncol 93(2):275–278. https://doi.org/10.1007/s11060-008-9771-6
Kawai N, Miyake K, Nishiyama Y, Yamamoto Y, Sasakawa Y, Haba R, Kushida Y, Tamiya T, Nagao S (2006) FDG-PET findings of the brain in lymphomatoid granulomatosis. Ann Nucl Med 20(10):683–687. https://doi.org/10.1007/bf02984680
Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83–87
Kano Y, Kodaira M, Ushiki A, Kosaka M, Yamada M, Shingu K, Nishihara H, Hanaoka M, Sekijima Y (2017) The complete remission of acquired immunodeficiency syndrome-associated isolated central nervous system lymphomatoid granulomatosis: a case report and review of the literature. Intern Med 56(18):2497–2501. https://doi.org/10.2169/internalmedicine.8776-16
Acknowledgments
The authors are grateful to the patient and his family. The study was supported by Key Technology Research and Development Program of Shandong (Project Numbers: 2011GGH21838, 2015GGH318020, 2016GSF201068).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from the patient.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Xiang, Y., Yan, P., Li, S. et al. Primary central nervous system lymphomatoid granulomatosis: a case report. Neurol Sci 42, 1587–1590 (2021). https://doi.org/10.1007/s10072-020-04833-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04833-4